These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11593927)
1. Inflammatory markers of ischemic coronary syndromes. Manzoli A; Patti G; Di Sciascio G Ital Heart J; 2001 Sep; 2 Suppl 3():29S-30S. PubMed ID: 11593927 [No Abstract] [Full Text] [Related]
2. Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy. Chirinos JA; Zambrano JP; Chakko S; Schob A; Veerani A; Perez GO; Mendez AJ Am J Cardiol; 2005 Jan; 95(1):88-90. PubMed ID: 15619397 [TBL] [Abstract][Full Text] [Related]
3. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein]. Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386 [TBL] [Abstract][Full Text] [Related]
4. [Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome]. Fragoso-Lona JM; Ramírez-Bello J; Cruz-Robles D; Pérez-Méndez O; de la Peña A; Vargas-Alarcón G Arch Cardiol Mex; 2009; 79(1):54-62. PubMed ID: 19545076 [TBL] [Abstract][Full Text] [Related]
5. [Inflammatory and anti-inflammatory markers in acute coronary syndromes. Ready for use in the clinical setting?]. García-Moll X Rev Esp Cardiol; 2005 Jun; 58(6):615-7. PubMed ID: 15970115 [No Abstract] [Full Text] [Related]
6. [Possible association between serum C-reactive protein concentrations and ischemic heart disease]. Shapira I; Zeltzer D; Berliner S Harefuah; 1999 Aug; 137(3-4):149-53. PubMed ID: 10959309 [No Abstract] [Full Text] [Related]
7. Atherosclerosis: an inflammatory disease. Liuzzo G Rays; 2001; 26(4):221-30. PubMed ID: 12696277 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers as predictors of clinical outcome in acute coronary syndromes. Mulvihill NT; Boccalatte M; Foley JB Minerva Cardioangiol; 2002 Dec; 50(6):653-9. PubMed ID: 12473985 [TBL] [Abstract][Full Text] [Related]
9. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800 [TBL] [Abstract][Full Text] [Related]
10. How to study the effects of inflammation on coronary vasomotion and their clinical relevance. Gaspardone A; Tomai F Ital Heart J; 2002 Apr; 3(4):226-9. PubMed ID: 12025370 [TBL] [Abstract][Full Text] [Related]
11. Fluctuating inflammatory markers in patients with stable ischemic heart disease. Bogaty P; Brophy JM; Boyer L; Simard S; Joseph L; Bertrand F; Dagenais GR Arch Intern Med; 2005 Jan; 165(2):221-6. PubMed ID: 15668370 [TBL] [Abstract][Full Text] [Related]